慢加急性乙型肝炎肝衰竭患者乙型肝炎病毒前C/CP区变异研究进展*

doi:10.3969/j.issn.1672-5069.2016.02.035

Abstract

Abstract: Acute-on-chronic liver failure （ACLF） is common type of liver failure,with poor prognosis and high mortality. Hepatitis B virus（HBV）infection is the major cause of ACLF in China. HBV precore/core promoter（PC/CP） region gene mutation is closely related to the occurrence of ACLF. In this article,we reviewed the structure and functions, biological change by mutations of HBV precore/core promoter, and immunopathogenetic mechanisms of ACLF.

Key words: Acute-on-chronic liver failure, Hepatitis B virus, Precore region, Core promoter, Mutation

Huang Pengyu, Xu Dongping. Precore and core promoter mutations of hepatitis B virus and their roles in acute-on-chronic liver failure[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(2): 241-244.

References

[1] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南（2010年版）.实用肝脏病杂志,2011,14（2）：81-89.
[2] You SL, Rong YH, Zhu B, et al. Changing etiology of liver failure in 3916 patients from northern China:a 10-year survey. Hepatol Int,2013,7（2）:714-720.
[3] Chisari FV, Isogawa M, Wieland S. Pathogenesis of hepatitis B virus infection. Pathol Biol（Paris）,2010,58（4）:258-266.
[4] Olson JC, Kamath PS. Acute-on-chronic liver failure:concept, natural history, and prognosis. Curr Opin Crit Care,2011,17（2）:165-169.
[5] Jules L,Dienstag, MD. Hepatitis B Virus Infection. N Engl J Med,2008,359（14）:1486-1500.
[6] Malik A,Singhal DK,Albanyan A,et al. Hepatitis B virus gene mutations in liver diseases:a report from New Delhi. PLoS One,2012,7（6）:e39028.
[7] Lai CL,Yuen MF. Chronic hepatitis B-New goals, new treatment. N Engl J Med,2008,359（23）:2488-2491.
[8] Orito E,Ichida T,Sakugawa H,et al. Geographic distribution of hepatitis B virus（HBV） genotype in patients with chronic HBV infection in Japan.Hepatology,2001,34（3）:590-594.
[9] B-ttcher B,Wynne SA,Crowther RA. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy.Nature,1997,386（6620）:88-91.
[10] Zhang D,Ma SF,Zhang X,et al. Prevalent HBV point mutations and mutation combinations at BCP/preC region and their association with liver disease progression.BMC Infect Dis,2010,10:271.
[11] 骆抗先. 乙型肝炎基础和临床. 3版.北京:人民卫生出版社,2006:78-90.
[12] Carman WF,Zanetti AR,Karayiannis P,et al. Vaccine-induced escape mutant of hepatitis B virus.Lancet,1990,336（8711）:325-329.
[13] 徐东平. 乙型肝炎病毒的病毒学特点及其临床意义.解放军医学杂志,2009,34（6）:655-658.
[14] 李春青,荀运浩,过建春.HBV前C/BCP区变异与重型乙型肝炎相关性的研究进展.中西医结合肝病杂志,2010,20（5）:315-317.
[15] 任晓强,许智慧,刘志国,等. 958例乙型肝炎患者HBV前C/BCP区变异检测及其意义分析.解放军医学杂志,2009,34（6）:663-665.
[16] Tu WH,Lyu Y,Zhang YM,et al. Precore/basal core promoter mutants quantification throug-hout phases of hepatitis B virus-infection by Simpleprobe. World J Gastroenterol,2015,21（21）:6639-6648.
[17] 陈风娟,王甦. 肝细胞核因子4α在肝脏疾病中的研究进展. 医学理论,2013,26（5）:590-592.
[18] Okamoto H, Tsuda F,Akahane Y,et al. Hepatitis B virus with mutations in the e antigen-negative phenotype in carriers with e antibody to e antigen. Virology,1994,68（12）:8102-8110.
[19] Buckwold VE, Xu ZC,Chen M,et al. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication.V irology,1996,70（9）:5845-5851.
[20] Tang H,Banks KE,Anderson AL,et al. Hepatitis B virus transcription and replication. Drug News Prespect,2001,14（6）:325-334.
[21] 李梵,徐东平.乙型肝炎病毒基因突变与临床疾病进展的关系.实用肝脏病杂志,2014,17（2）:210-213.
[22] Peng Y,Liu B,Hou J,et al. Naturally occurring deletions/insertions in HBV core promoter tend to decrease in HBeAgpositive chronic hepatitis B patients during antiviral therapy.Antivir Ther,2015,10:3851/IMP2955.
[23] Qu L, Kuai X,Liu T,et al. Pre-S deletion and complex mutations of hepatitis B virus related to young age hepatocellular carcinoma in Qidong,China. PLoS One,2013,8（3）:e59583.
[24] Juniastuti D,Utsumi T,Aksono EB,et al. Predominance of precore mutations and clinical significance of basal core promoter mutations in chronic hepatitis B virus infection in Indonesia. Biomed Rep,2013,1（4）:522-528.
[25] 王耀,刘妍,许智慧,等. G1764A/C1766T/T1768A三联突变对HBV核心启动子活性的上调作用的研究.解放军医学杂志,2010,35（8）:954-957.
[26] Kitab B,Essaid El Feydi A,Afifi R,et al. Variability in the precore and core promoter regions of HBV strains in Morocco: Characterization and impact on liver disease progression. PLoS One,2012,7（8）:e42891.
[27] 中华医学会感染病学分会肝衰竭与人工肝学组.肝衰竭诊治指南（2012年版）. 实用肝脏病杂志,2013,16（3）:210-216.
[28] 黄湛镰,高志良.肝衰竭的三重打击及治疗策略.内科急危重症杂志,2014,20（3）:154-156.
[29] 李晓东,徐东平.HBV相关慢加急性肝衰竭免疫病理发病机制研究进展.实用肝脏病杂志,2015,18（3）:317-320.
[30] 杨玲,曾文铤,梁增伟,等.BCP/前C及A1846T变异与HBV导致的慢加急性肝衰竭发病相关研究.热带医学杂志,2013,13（9）:1095-1097.
[31] Ren X,Xu Z,Liu Y,et al. Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B related acute on chronic liver failure without preexisting liver cirrhosis. J Viral Hepat,2010,17（12）:887-895.
[32] Xu Z,Ren X,Liu Y,et al. Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of793 Chinese patients with mild and severe chronic hepatitis B and acute on chronic liver failure.J Gastroenterol,2011,46（3）:391-400.
[33] Zhang A,Wan Z,You S,et al. Association of hepatitis B virus mutations of A1846T and C1913A/G with acute on chronic liver failure development from different underlying chronic liver diseases.Hepat Mon,2013,13（9）:e12445.
[34] Xiao L,Zhou B,Gao H,et al. Hepatitis B virus genotype B with G1896A and A1762T/G1764A mutations is associated with hepatitis B related acute on chronic liver Failure. J Med Virol,2011,83:1544-1550.
[35] Hu F, Bi S,Yan H,et al. Associations between hepatitis B virus basal core promoter/precore region mutations and the risk of acute on chronic liver failure:a meta-analysis. Virol J,2015,12:87.

Precore and core promoter mutations of hepatitis B virus and their roles in acute-on-chronic liver failure

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[2]	Wang Yuan, Dang Panyu, Wang Wei. Application of plasma exchange and continuous plasma dialysis filtration in the treatment of patients with acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 541-544.
[3]	Peng Silu, Liu Bing, Sun Hong, et al. Prognosis of patients with hepatitis B-induced acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 545-548.
[4]	Zhong Song, Liu Yuyuan, Liu Shuren. G2D expression of peripheral blood natural killer cells in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 341-344.
[5]	Zhang Huanhuan, Yang Huan, Shen Silan, et al.. Distribution of HBV genotypes and drug-resistant mutations in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 41-44.
[6]	Chen Haiou, Liu Shi.. Implication of serum IL-10 and GP73 levels in patients with HBV-related acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 73-76.
[7]	Ma Deyuan, Ma Yuanfeng, Zhang Dianlong, et al.. Prognostic efficacy of serum keratin 18 in patients with hepatitis B virus-related acute on chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 77-80.
[8]	Yan Huanjie, Zhang Shuqin, Zhao Wenjing.. Therapeutic efficacy of autologous bone marrow stem cell transplantation for treatment of patients with hepatitis B-induced acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 81-84.
[9]	Zhang Jing, Yin Fang, Luo Guanhong, et al.. Effect of plasma exchange and sequential double plasma molecular adsorbent therapy on short survival in patients with hepatitis B virus-induced acute on chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 85-88.
[10]	Yu Xutong, Jiang Xiuhua, Qi Tingting, et al.. Verification of bleeding criteria in patients with acute-on-chronic liver failure: A prospective study [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 885-889.
[11]	Wang Yan, Wu Qiqi, Zhuang Xiaofang, et al.. Polymorphism of blood IFN-γ gene in patients with hepatitis B induced acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 890-894.
[12]	ZhangLining, Liu Zhigang, GaoCaixia, et al.. Application of dietary intervention with authorized education in patients with hepatitis B virus associated glomerulonephritis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 799-800.
[13]	Li Lei, Hu Hui, Zheng Xiaowei, et al. Prediction of short-term survival by four scoring systems based on MELD in patients with acute-on-chronic hepatitis B-induced liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 417-420.
[14]	Wang Ping, Zhou Xiaojia, Liu Xinhua. Application of video-based health education in patients with hepatitis B virus associated glomerulonephritis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 451-452.
[15]	Weng Yerui, Fu Aizhen. Investigation of milk HBV DNA in pregnant women with chronic HBV infection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 457-458.